The FDA’s latest draft guidance on accelerated approval for new drugs, “Expedited Program for Serious Conditions—Accelerated ...

addressed challenges with the current accelerated approval pathway, which was created in 1992 to offer patients a way to gain access to novel therapies ahead of final results of a phase 3 trial.

The Minns Labor Government has awarded funding to a Newcastle-based researcher focussed on improving outcomes for regional and rural cancer patients ...

In honor of Rare Disease Day on February 28, 2025, we will publish a series of posts throughout the month on As Prescribed and Health Law ...

The global breast cancer therapeutics market is expected to grow from US$ 31.07 billion in 2022 to US$ 63.9 billion by 2030, ...

Trial Library collaborates with American Oncology Network to expand clinical trial access for patients with various cancers: San Francisco Saturday, March 15, 2025, 18:00 Hrs [IST ...

SAN JOSE, Calif., March 18, 2025 /PRNewswire/ -- At NVIDIA GTC 2025, ThisWay Global is unveiling how it enabled Humanate Digital to transform years of fragmented research into actionable intelligence ...

This accelerated pathway for new drugs and therapies ... Intelligence and learnings from the delivery of the early and managed patient access schemes will be used to better understand impact ...

It’s not clear how many other pediatric cancer patients are currently waiting for access to the drug in Canada and the ...

However, fresh evidence from the HHS’ watchdog shows the problem is not a pushover FDA. If anything, the problem is a ...